This series bridges the gap between research and patient care by providing medical oncologists and hematologists with ongoing access to the perspectives and opinions of national and international clinical investigators with expertise in gastrointestinal cancers.
Gastroesophageal Cancers — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:
Introduction (0:00)
First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48)
Management of HER2-Positive Gastroesophageal Cancer (25:11)
Neoadjuvant Therapy for Gastroesophageal Cancer (45:13)
Note to listeners: Subsequent to the recording of this symposium, the FDA approved zanidatamab in combination with chemotherapy with and without tislelizumab for HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma based on results from the Phase III HERIZON-GEA-01 trial.
CME information and select publications (https://researchtopractice.com/activity/integrating-new-advances-into-community-oncology-practice-4/)
24 Aug 2026
For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Ms Caroline Kuhlman, Dr Eileen M O'Reilly, Dr Philip A Philip and Ms Amanda K Wagner, moderated by Dr O'Reilly, including the following topics:
Introduction (0:00)
Clinical Presentation and Prognosis of Pancreatic Adenocarcinoma (PAD) (3:29)
Recent Advances in Up-Front Treatment for Metastatic PAD (15:47)
Selection and Sequencing of Therapy for Relapsed/Refractory Metastatic PAD (39:58)
Novel Strategies Targeting RAS Mutations in Advanced PAD (48:20)
Utility of Tumor Treating Fields in PAD Management (1:13:58)
CME information and select publications (https://researchtopractice.com/ONS2026/Pancreatic/Video)
20 Aug 2026
Gastroesophageal Cancers — Year in Review Series on Relevant New Datasets and Advances
Featuring perspectives from Dr David H Ilson and Dr Kohei Shitara, including the following topics:
Introduction (0:00)
Biomarker Evaluation in Localized and Metastatic Disease (1:49)
Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — Dr Ilson (7:37)
Other Available Therapeutic Approaches — Dr Shitara (33:22)
CME information and select publications (https://researchtopractice.com/YIR2025/GE/Video)
Who has been a guest on Gastrointestinal Cancer Update
Names identified in recent episode analyses. Showing up to five guests.
Farshid Dayyani
Philip A Philip
Caroline Kuhlman
Amanda K Wagner
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.2 / 5
18 ratings
Podcast Authority Score: 44 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
67
Social presence
0
YouTube
0
Engagement
50
Contact Gastrointestinal Cancer Update
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
